{"transactions":[{"id":691874,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2026-08-11T01:33:02.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":false,"shares":400,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 6, 2025, the reporting person was granted 7,200 (400 post-split) RSUs, vesting on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":400},"source":{"system":"sec-edgar","filing":"0001193125-26-343069","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343069/ownership.xml","form_type":"4"}},{"id":691873,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-08-11T01:33:02.000Z","date":"2026-08-06","kind":"exercise","planned":false,"acquired":true,"shares":400,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":400,"source":{"system":"sec-edgar","filing":"0001193125-26-343069","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000119312526343069/ownership.xml","form_type":"4"}},{"id":1071385,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-08-08T20:36:41.000Z","date":"2025-08-06","kind":"grant","planned":false,"acquired":true,"shares":7200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":7200,"derivative":{"underlying":"Common Stock","underlying_shares":7200},"source":{"system":"sec-edgar","filing":"0000950170-25-105942","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025105942/ownership.xml","form_type":"4"}},{"id":1084037,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2025-07-21T20:41:34.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":false,"shares":1,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On July 17, 2024, the reporting person was granted 925 (1 post-splits) RSUs, vesting in full one year from the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1},"source":{"system":"sec-edgar","filing":"0000950170-25-097279","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097279/ownership.xml","form_type":"4"}},{"id":1084036,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-07-21T20:41:34.000Z","date":"2025-07-17","kind":"exercise","planned":false,"acquired":true,"shares":1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0000950170-25-097279","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017025097279/ownership.xml","form_type":"4"}},{"id":1451190,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-07-19T20:30:28.000Z","date":"2024-07-17","kind":"grant","planned":false,"acquired":true,"shares":925,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":925,"derivative":{"underlying":"Common Stock","underlying_shares":925},"source":{"system":"sec-edgar","filing":"0000950170-24-084944","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024084944/ownership.xml","form_type":"4"}},{"id":1495158,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:44.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":false,"shares":81,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On June 2, 2023, the reporting person was granted 3,571 (81 post-split) RSUs, vesting in full on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":81},"source":{"system":"sec-edgar","filing":"0000950170-24-068070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068070/ownership.xml","form_type":"4"}},{"id":1495157,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2024-06-03T20:58:44.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":false,"shares":7,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On June 1, 2021, the reporting person was granted 893 (20 post-split) RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":7},"source":{"system":"sec-edgar","filing":"0000950170-24-068070","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068070/ownership.xml","form_type":"4"}},{"id":1495156,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:58:44.000Z","date":"2024-06-02","kind":"exercise","planned":false,"acquired":true,"shares":81,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":277,"source":{"system":"sec-edgar","filing":"0000950170-24-068070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068070/ownership.xml","form_type":"4"}},{"id":1495155,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-03T20:58:44.000Z","date":"2024-06-01","kind":"exercise","planned":false,"acquired":true,"shares":7,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"On March 5, 2024, the Issuer effected a 1-for-44 reverse stock split of its common stock (the \"Reverse Stock Split\"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split."}],"balance_after":196,"source":{"system":"sec-edgar","filing":"0000950170-24-068070","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000095017024068070/ownership.xml","form_type":"4"}},{"id":1810870,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-08-10T20:05:40.000Z","date":"2023-08-09","kind":"exercise","planned":false,"acquired":false,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 3,571 RSUs, vesting in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On August 9, 2022, the reporting person was granted 3,571 RSUs, vesting in full on the first anniversary of the date of grant."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001209191-23-045294","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123045294/doc4.xml","form_type":"4"}},{"id":1810869,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-08-10T20:05:40.000Z","date":"2023-08-09","kind":"exercise","planned":false,"acquired":true,"shares":3571,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":8339,"source":{"system":"sec-edgar","filing":"0001209191-23-045294","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123045294/doc4.xml","form_type":"4"}},{"id":1869921,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-02T20:43:05.000Z","date":"2023-06-02","kind":"grant","planned":false,"acquired":true,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":3571,"derivative":{"underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001209191-23-033830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123033830/doc4.xml","form_type":"4"}},{"id":1869920,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2023-06-02T20:43:05.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":false,"shares":297,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":298,"derivative":{"underlying":"Common Stock","underlying_shares":297},"source":{"system":"sec-edgar","filing":"0001209191-23-033830","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123033830/doc4.xml","form_type":"4"}},{"id":1869919,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-02T20:43:05.000Z","date":"2023-06-01","kind":"exercise","planned":false,"acquired":true,"shares":297,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":4768,"source":{"system":"sec-edgar","filing":"0001209191-23-033830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919123033830/doc4.xml","form_type":"4"}},{"id":2189424,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-08-10T20:09:31.000Z","date":"2022-08-09","kind":"grant","acquired":true,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vest in full on the first anniversary of the date of grant."}],"balance_after":3571,"derivative":{"underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001209191-22-045184","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122045184/doc4.xml","form_type":"4"}},{"id":2244762,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2022-06-03T19:16:30.000Z","date":"2022-06-01","kind":"exercise","acquired":false,"shares":298,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"On June 1, 2021, the reporting person was granted 893 RSUs, vesting in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":595,"derivative":{"underlying":"Common Stock","underlying_shares":298},"source":{"system":"sec-edgar","filing":"0001209191-22-033936","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122033936/doc4.xml","form_type":"4"}},{"id":2244761,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-03T19:16:30.000Z","date":"2022-06-01","kind":"exercise","acquired":true,"shares":298,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Restricted Stock Units (\"RSUs\") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis."}],"balance_after":8108,"source":{"system":"sec-edgar","filing":"0001209191-22-033936","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000120919122033936/doc4.xml","form_type":"4"}},{"id":2677137,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-08T20:13:47.000Z","date":"2021-06-04","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following June 4, 2021."}],"balance_after":10000,"derivative":{"exercise_price":35.52,"expiration_date":"2031-06-04","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-21-004122","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380187/000156218021004122/primarydocument.xml","form_type":"4"}},{"id":2686610,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2021-06-02T23:32:14.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":893,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted stock units (the \"RSUs\") convert into shares of the Issuer's common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on June 1, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vest in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":893,"derivative":{"underlying":"Common Stock","underlying_shares":893},"source":{"system":"sec-edgar","filing":"0001019056-21-000353","document":"abdunnabi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905621000353/abdunnabi.xml","form_type":"4"}},{"id":2686609,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-06-02T23:32:14.000Z","date":"2021-06-01","kind":"grant","acquired":true,"shares":2678,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on June 1, 2022."}],"balance_after":2678,"derivative":{"exercise_price":26.15,"expiration_date":"2031-06-01","underlying":"Common Stock","underlying_shares":2678},"source":{"system":"sec-edgar","filing":"0001019056-21-000353","document":"abdunnabi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905621000353/abdunnabi.xml","form_type":"4"}},{"id":2854808,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-18T01:59:41.000Z","date":"2020-07-02","kind":"grant","acquired":true,"shares":3571,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three approximately equal annual installments beginning on July 2, 2021."}],"balance_after":3571,"derivative":{"exercise_price":9.18,"expiration_date":"2030-07-02","underlying":"Common Stock","underlying_shares":3571},"source":{"system":"sec-edgar","filing":"0001019056-21-000139","document":"abdunnabi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905621000139/abdunnabi.xml","form_type":"4"}},{"id":3074029,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-30T01:11:47.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":170,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"These options will vest in three approximately equal annual installments beginning on the one year anniversary of the date of grant."}],"balance_after":170,"derivative":{"exercise_price":8.56,"expiration_date":"2030-07-26","underlying":"Common Stock","underlying_shares":170},"source":{"system":"sec-edgar","filing":"0001019056-20-000433","document":"abdunnabi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000433/abdunnabi.xml","form_type":"4"}},{"id":3074028,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-30T01:11:47.000Z","date":"2020-07-27","kind":"grant","acquired":true,"shares":1322,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"These options vest in full on the one year anniversary of the date of grant."}],"balance_after":1322,"derivative":{"exercise_price":8.56,"expiration_date":"2030-07-26","underlying":"Common Stock","underlying_shares":1322},"source":{"system":"sec-edgar","filing":"0001019056-20-000433","document":"abdunnabi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000433/abdunnabi.xml","form_type":"4"}},{"id":3074027,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-30T01:11:47.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":1785,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"These options provide for vesting in three approximately equal annual installments beginning on May 31, 2019. Prior to July 27, 2020, all but 595 shares of the issuer's common stock underlying this stock option had vested."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":76.86,"expiration_date":"2028-06-01","underlying":"Common Stock","underlying_shares":1785},"source":{"system":"sec-edgar","filing":"0001019056-20-000433","document":"abdunnabi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000433/abdunnabi.xml","form_type":"4"}},{"id":3074026,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-30T01:11:47.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":892,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"These options vested in three approximately equal annual installments beginning on June 1, 2018."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":30.1,"expiration_date":"2027-06-01","underlying":"Common Stock","underlying_shares":892},"source":{"system":"sec-edgar","filing":"0001019056-20-000433","document":"abdunnabi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000433/abdunnabi.xml","form_type":"4"}},{"id":3074025,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-07-30T01:11:47.000Z","date":"2020-07-27","kind":"disposition_to_issuer","acquired":false,"shares":1339,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"In connection with the issuer's offer exchange program described in the issuer's tender offer statement on Schedule TO filed by the issuer with the Securities and Exchange Commission on June 29, 2020, as amended, on July 27, 2020 the issuer cancelled certain of the reporting person's options to acquire shares of the issuer's common stock and, in exchange thereof, granted the reporting person new options to acquire shares of the issuer's common stock, in each case, as reported on this Form 4."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"These options vested in three approximately equal annual installments beginning on August 3, 2017."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Reflects a 1-for-14 reverse stock split of the issuer's common stock effective as of March 26, 2020."}],"balance_after":0,"derivative":{"exercise_price":41.16,"expiration_date":"2026-08-03","underlying":"Common Stock","underlying_shares":1339},"source":{"system":"sec-edgar","filing":"0001019056-20-000433","document":"abdunnabi.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905620000433/abdunnabi.xml","form_type":"4"}},{"id":3126578,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-02T20:30:04.000Z","date":"2020-05-29","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 29, 2020."}],"balance_after":10000,"derivative":{"exercise_price":37.66,"expiration_date":"2030-05-29","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-20-004062","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380187/000156218020004062/primarydocument.xml","form_type":"4"}},{"id":3478747,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false,"officer_title":"Board of Directors"}}],"security":"Common Stock","published_at":"2019-06-25T23:11:55.000Z","date":"2019-06-25","kind":"purchase","acquired":true,"shares":16667,"price":0.9,"value":15000.3,"ownership":{"direct":true},"balance_after":109351,"source":{"system":"sec-edgar","filing":"0001593968-19-001480","document":"primary_01.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000159396819001480/primary_01.xml","form_type":"4"}},{"id":3501800,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-04T20:16:43.000Z","date":"2019-05-31","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 31, 2019."}],"balance_after":10000,"derivative":{"exercise_price":43.02,"expiration_date":"2029-05-31","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001562180-19-003290","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380187/000156218019003290/primarydocument.xml","form_type":"4"}},{"id":3502508,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false,"officer_title":"Board of Directors"}}],"security":"Option (right to buy)","published_at":"2019-06-04T16:54:53.000Z","date":"2019-06-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option was granted on June 1, 2019 and becomes exercisable in three equal annual installments beginning on June 1, 2020."}],"balance_after":25000,"derivative":{"exercise_price":0.725,"exercise_date":"2020-06-01","expiration_date":"2029-06-01","underlying":"Aptevo Therapeutics Inc. common stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001593968-19-001273","document":"primary_01.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000159396819001273/primary_01.xml","form_type":"4"}},{"id":3618136,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-03-04T23:39:36.000Z","date":"2019-03-04","kind":"sale","acquired":false,"shares":14565,"price":58.107,"value":846328.455,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is the weighted average price.  These shares were sold in multiple transactions at prices ranging from $56.74 to $59.66, inclusive."}],"balance_after":142617,"source":{"system":"sec-edgar","filing":"0001567619-19-006066","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919006066/doc1.xml","form_type":"4"}},{"id":3625791,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-03-01T00:03:41.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":5101,"price":58.71,"value":299479.71,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":157182,"source":{"system":"sec-edgar","filing":"0001567619-19-005673","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005673/doc1.xml","form_type":"4"}},{"id":3625790,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-03-01T00:03:41.000Z","date":"2019-02-27","kind":"tax_withholding","acquired":false,"shares":2570,"price":57.98,"value":149008.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":162283,"source":{"system":"sec-edgar","filing":"0001567619-19-005673","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005673/doc1.xml","form_type":"4"}},{"id":3625789,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2019-03-01T00:03:41.000Z","date":"2019-02-26","kind":"tax_withholding","acquired":false,"shares":1714,"price":61.01,"value":104571.14,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":164853,"source":{"system":"sec-edgar","filing":"0001567619-19-005673","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005673/doc1.xml","form_type":"4"}},{"id":3812414,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-18T20:09:01.000Z","date":"2018-09-17","kind":"exercise","acquired":true,"shares":1319,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":13.38,"expiration_date":"2020-03-11","underlying":"Common Stock","underlying_shares":1319},"source":{"system":"sec-edgar","filing":"0001567619-18-002811","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918002811/doc1.xml","form_type":"4"}},{"id":3812413,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-18T20:09:01.000Z","date":"2018-09-14","kind":"exercise","acquired":true,"shares":28220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant vested in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":1319,"derivative":{"exercise_price":13.38,"expiration_date":"2020-03-11","underlying":"Common Stock","underlying_shares":28220},"source":{"system":"sec-edgar","filing":"0001567619-18-002811","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918002811/doc1.xml","form_type":"4"}},{"id":3812412,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-18T20:09:01.000Z","date":"2018-09-17","kind":"sale","acquired":false,"shares":1319,"price":65,"value":85735.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."}],"balance_after":166567,"source":{"system":"sec-edgar","filing":"0001567619-18-002811","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918002811/doc1.xml","form_type":"4"}},{"id":3812411,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-18T20:09:01.000Z","date":"2018-09-17","kind":"exercise","acquired":true,"shares":1319,"price":13.38,"value":17648.22,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."}],"balance_after":167886,"source":{"system":"sec-edgar","filing":"0001567619-18-002811","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918002811/doc1.xml","form_type":"4"}},{"id":3812410,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-18T20:09:01.000Z","date":"2018-09-14","kind":"sale","acquired":false,"shares":28220,"price":65,"value":1834300.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."}],"balance_after":166567,"source":{"system":"sec-edgar","filing":"0001567619-18-002811","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918002811/doc1.xml","form_type":"4"}},{"id":3812409,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-18T20:09:01.000Z","date":"2018-09-14","kind":"exercise","acquired":true,"shares":28220,"price":13.38,"value":377583.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."}],"balance_after":194787,"source":{"system":"sec-edgar","filing":"0001567619-18-002811","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918002811/doc1.xml","form_type":"4"}},{"id":3823094,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-09-06T21:51:42.000Z","date":"2018-09-04","kind":"exercise","acquired":false,"shares":60000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":29539,"derivative":{"exercise_price":13.38,"expiration_date":"2020-03-11","underlying":"Common Stock","underlying_shares":60000},"source":{"system":"sec-edgar","filing":"0001567619-18-002215","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918002215/doc1.xml","form_type":"4"}},{"id":3823093,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-06T21:51:42.000Z","date":"2018-09-05","kind":"sale","acquired":false,"shares":30776,"price":59.4926,"value":1830944.2576,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $58.35 to $60.67, inclusive."}],"balance_after":166567,"source":{"system":"sec-edgar","filing":"0001567619-18-002215","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918002215/doc1.xml","form_type":"4"}},{"id":3823092,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-06T21:51:42.000Z","date":"2018-09-04","kind":"sale","acquired":false,"shares":60000,"price":60.5381,"value":3632286.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $59.36 to $62.00, inclusive."}],"balance_after":197343,"source":{"system":"sec-edgar","filing":"0001567619-18-002215","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918002215/doc1.xml","form_type":"4"}},{"id":3823091,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2018-09-06T21:51:42.000Z","date":"2018-09-04","kind":"exercise","acquired":true,"shares":60000,"price":13.38,"value":802800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."}],"balance_after":257343,"source":{"system":"sec-edgar","filing":"0001567619-18-002215","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761918002215/doc1.xml","form_type":"4"}},{"id":3901282,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2018-06-07T21:07:08.000Z","date":"2018-06-05","kind":"sale","acquired":false,"shares":15785,"price":52.1137,"value":822614.7545,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.83 to $52.66. inclusive."}],"balance_after":197343,"source":{"system":"sec-edgar","filing":"0001140361-18-027713","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118027713/doc1.xml","form_type":"4"}},{"id":3908530,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-04T22:48:34.000Z","date":"2018-06-01","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on May 31, 2019."}],"balance_after":25000,"derivative":{"exercise_price":5.49,"expiration_date":"2028-05-31","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001019056-18-000778","document":"abdunnabi_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905618000778/abdunnabi_4.xml","form_type":"4"}},{"id":3913806,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-05-30T20:25:13.000Z","date":"2018-05-25","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 25, 2018."}],"balance_after":12500,"derivative":{"exercise_price":49.45,"expiration_date":"2028-05-25","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-18-002713","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380187/000156218018002713/primarydocument.xml","form_type":"4"}},{"id":3997695,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-03-13T21:53:37.000Z","date":"2018-03-09","kind":"tax_withholding","acquired":false,"shares":7825,"price":51.84,"value":405648.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":213128,"source":{"system":"sec-edgar","filing":"0001140361-18-013315","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118013315/doc1.xml","form_type":"4"}},{"id":4023331,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-03-01T22:01:15.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":53485,"price":49.64,"value":2654995.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments on February 26, 2019, February 26, 2020 and February 26, 2021."}],"balance_after":53485,"derivative":{"exercise_price":49.64,"expiration_date":"2025-02-26","underlying":"Common Stock","underlying_shares":53485},"source":{"system":"sec-edgar","filing":"0001140361-18-011280","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011280/doc1.xml","form_type":"4"}},{"id":4023330,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-03-01T22:01:15.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":6599,"price":49.97,"value":329752.03,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":220953,"source":{"system":"sec-edgar","filing":"0001140361-18-011280","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011280/doc1.xml","form_type":"4"}},{"id":4023329,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-03-01T22:01:15.000Z","date":"2018-02-27","kind":"tax_withholding","acquired":false,"shares":3324,"price":49.64,"value":165003.36,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":227552,"source":{"system":"sec-edgar","filing":"0001140361-18-011280","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011280/doc1.xml","form_type":"4"}},{"id":4023328,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-03-01T22:01:15.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":13371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2020 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period."}],"balance_after":230876,"source":{"system":"sec-edgar","filing":"0001140361-18-011280","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011280/doc1.xml","form_type":"4"}},{"id":4023327,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-03-01T22:01:15.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":13371,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":217505,"source":{"system":"sec-edgar","filing":"0001140361-18-011280","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011280/doc1.xml","form_type":"4"}},{"id":4106813,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-01-04T21:31:40.000Z","date":"2018-01-02","kind":"exercise","acquired":false,"shares":21906,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":14.44,"expiration_date":"2019-03-12","underlying":"Common Stock","underlying_shares":21906},"source":{"system":"sec-edgar","filing":"0001140361-18-000849","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118000849/doc1.xml","form_type":"4"}},{"id":4106812,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-01-04T21:31:40.000Z","date":"2018-01-02","kind":"sale","acquired":false,"shares":21906,"price":47.91,"value":1049516.46,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $47.62 to $48.13, inclusive."}],"balance_after":204134,"source":{"system":"sec-edgar","filing":"0001140361-18-000849","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118000849/doc1.xml","form_type":"4"}},{"id":4106811,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2018-01-04T21:31:40.000Z","date":"2018-01-02","kind":"exercise","acquired":true,"shares":21906,"price":14.44,"value":316322.64,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."}],"balance_after":226040,"source":{"system":"sec-edgar","filing":"0001140361-18-000849","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118000849/doc1.xml","form_type":"4"}},{"id":4131332,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-12-14T21:57:37.000Z","date":"2017-12-13","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":21906,"derivative":{"exercise_price":14.44,"expiration_date":"2019-03-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-17-046253","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117046253/doc1.xml","form_type":"4"}},{"id":4131331,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-12-14T21:57:37.000Z","date":"2017-12-13","kind":"sale","acquired":false,"shares":20000,"price":45.99,"value":919800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $45.55 to $46.24, inclusive."}],"balance_after":204134,"source":{"system":"sec-edgar","filing":"0001140361-17-046253","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117046253/doc1.xml","form_type":"4"}},{"id":4131330,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-12-14T21:57:37.000Z","date":"2017-12-13","kind":"exercise","acquired":true,"shares":20000,"price":14.44,"value":288800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."}],"balance_after":224134,"source":{"system":"sec-edgar","filing":"0001140361-17-046253","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117046253/doc1.xml","form_type":"4"}},{"id":4170002,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T21:07:08.000Z","date":"2017-11-03","kind":"exercise","acquired":false,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":41906,"derivative":{"exercise_price":14.44,"expiration_date":"2019-03-12","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001140361-17-041378","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117041378/doc1.xml","form_type":"4"}},{"id":4170001,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-11-07T21:07:08.000Z","date":"2017-11-03","kind":"exercise","acquired":false,"shares":11508,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":22.03,"expiration_date":"2018-03-14","underlying":"Common Stock","underlying_shares":11508},"source":{"system":"sec-edgar","filing":"0001140361-17-041378","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117041378/doc1.xml","form_type":"4"}},{"id":4170000,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-11-07T21:07:08.000Z","date":"2017-11-03","kind":"sale","acquired":false,"shares":20000,"price":42.92,"value":858400.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.70 to $43.00, inclusive."}],"balance_after":204134,"source":{"system":"sec-edgar","filing":"0001140361-17-041378","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117041378/doc1.xml","form_type":"4"}},{"id":4169999,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-11-07T21:07:08.000Z","date":"2017-11-03","kind":"exercise","acquired":true,"shares":20000,"price":14.44,"value":288800.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."}],"balance_after":224134,"source":{"system":"sec-edgar","filing":"0001140361-17-041378","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117041378/doc1.xml","form_type":"4"}},{"id":4169998,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-11-07T21:07:08.000Z","date":"2017-11-03","kind":"sale","acquired":false,"shares":11508,"price":42.5,"value":489090.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.47 to $42.78, inclusive."}],"balance_after":204134,"source":{"system":"sec-edgar","filing":"0001140361-17-041378","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117041378/doc1.xml","form_type":"4"}},{"id":4169997,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-11-07T21:07:08.000Z","date":"2017-11-03","kind":"exercise","acquired":true,"shares":11508,"price":22.03,"value":253521.24,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."}],"balance_after":215642,"source":{"system":"sec-edgar","filing":"0001140361-17-041378","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117041378/doc1.xml","form_type":"4"}},{"id":4198994,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-29T20:36:57.000Z","date":"2017-09-27","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":11508,"derivative":{"exercise_price":22.03,"expiration_date":"2018-03-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-17-036963","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117036963/doc1.xml","form_type":"4"}},{"id":4198993,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-09-29T20:36:57.000Z","date":"2017-09-27","kind":"sale","acquired":false,"shares":15000,"price":39.918,"value":598770.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.85 to $39.98, inclusive."}],"balance_after":204134,"source":{"system":"sec-edgar","filing":"0001140361-17-036963","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117036963/doc1.xml","form_type":"4"}},{"id":4198992,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-09-29T20:36:57.000Z","date":"2017-09-27","kind":"exercise","acquired":true,"shares":15000,"price":22.03,"value":330450.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."}],"balance_after":219134,"source":{"system":"sec-edgar","filing":"0001140361-17-036963","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117036963/doc1.xml","form_type":"4"}},{"id":4217571,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-09-05T21:16:37.000Z","date":"2017-08-31","kind":"exercise","acquired":false,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan as amended and restated."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":26508,"derivative":{"exercise_price":22.03,"expiration_date":"2018-03-14","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001140361-17-034333","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117034333/doc1.xml","form_type":"4"}},{"id":4217570,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-09-05T21:16:37.000Z","date":"2017-08-31","kind":"sale","acquired":false,"shares":15000,"price":37.21,"value":558150.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.14 to $37.27, inclusive."}],"balance_after":204134,"source":{"system":"sec-edgar","filing":"0001140361-17-034333","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117034333/doc1.xml","form_type":"4"}},{"id":4217569,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-09-05T21:16:37.000Z","date":"2017-08-31","kind":"exercise","acquired":true,"shares":15000,"price":22.03,"value":330450.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."}],"balance_after":219134,"source":{"system":"sec-edgar","filing":"0001140361-17-034333","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117034333/doc1.xml","form_type":"4"}},{"id":4298201,"issuer":{"id":8337,"kind":"organization","name":"Aptevo Therapeutics Inc."},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-06-02T01:36:07.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in three equal annual installments beginning on June 1, 2018."}],"balance_after":12500,"derivative":{"exercise_price":2.15,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001019056-17-000541","document":"abdunnabi_4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1671584/000101905617000541/abdunnabi_4.xml","form_type":"4"}},{"id":4302615,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-26T21:03:00.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in 12 equal monthly installments following May 24, 2017."}],"balance_after":12500,"derivative":{"exercise_price":18.85,"expiration_date":"2027-05-24","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0000899243-17-014578","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1380187/000089924317014578/doc4.xml","form_type":"4"}},{"id":4390458,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-03-11T02:10:56.000Z","date":"2017-03-10","kind":"tax_withholding","acquired":false,"shares":10738,"price":31.05,"value":333414.9,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":204134,"source":{"system":"sec-edgar","filing":"0001140361-17-011680","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117011680/doc1.xml","form_type":"4"}},{"id":4390457,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-03-11T02:10:56.000Z","date":"2017-03-09","kind":"tax_withholding","acquired":false,"shares":8226,"price":30.98,"value":254841.48,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":214872,"source":{"system":"sec-edgar","filing":"0001140361-17-011680","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117011680/doc1.xml","form_type":"4"}},{"id":4408612,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-03-03T02:29:16.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":78329,"price":30.63,"value":2399217.27,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments on February 27, 2018, February 27, 2019 and February 27, 2020."}],"balance_after":78329,"derivative":{"exercise_price":30.63,"expiration_date":"2024-02-27","underlying":"Common Stock","underlying_shares":78329},"source":{"system":"sec-edgar","filing":"0001140361-17-010390","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010390/doc1.xml","form_type":"4"}},{"id":4408611,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-03-03T02:29:16.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":6184,"price":30.63,"value":189415.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":223098,"source":{"system":"sec-edgar","filing":"0001140361-17-010390","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010390/doc1.xml","form_type":"4"}},{"id":4408610,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-03-03T02:29:16.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":19589,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2019 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period."}],"balance_after":229282,"source":{"system":"sec-edgar","filing":"0001140361-17-010390","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010390/doc1.xml","form_type":"4"}},{"id":4408609,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-03-03T02:29:16.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":19588,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":209693,"source":{"system":"sec-edgar","filing":"0001140361-17-010390","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010390/doc1.xml","form_type":"4"}},{"id":4413369,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Stock Option - (Right to Buy)","published_at":"2017-03-02T01:26:44.000Z","date":"2017-02-27","kind":"exercise","acquired":false,"shares":3662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of options granted under the Amended and Restated Emergent BioSolutions Inc 2006 Stock Incentive Plan, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vested in three equal installments in March 2011, March 2012 and March 2013."}],"balance_after":0,"derivative":{"exercise_price":14.51,"exercise_date":"2013-03-08","expiration_date":"2017-03-08","underlying":"Common stock","underlying_shares":3662},"source":{"system":"sec-edgar","filing":"0001140361-17-010111","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010111/doc1.xml","form_type":"4"}},{"id":4413368,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-03-02T01:26:44.000Z","date":"2017-02-27","kind":"tax_withholding","acquired":false,"shares":984,"price":30.63,"value":30139.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of options granted under the Amended and Restated Emergent BioSolutions Inc 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F4","text":"Consists of shares withheld from the option exercise and delivered to the issuer to satisfy the reporting persons tax withholding obligations."}],"balance_after":190105,"source":{"system":"sec-edgar","filing":"0001140361-17-010111","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010111/doc1.xml","form_type":"4"}},{"id":4413367,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-03-02T01:26:44.000Z","date":"2017-02-27","kind":"tax_withholding","acquired":false,"shares":1735,"price":30.63,"value":53143.05,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of options granted under the Amended and Restated Emergent BioSolutions Inc 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of shares owned by the reporting person and delivered to the issuer to satisfy the reporting persons exercise price for the reported stock options."}],"balance_after":191089,"source":{"system":"sec-edgar","filing":"0001140361-17-010111","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010111/doc1.xml","form_type":"4"}},{"id":4413366,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President & CEO"}}],"security":"Common Stock","published_at":"2017-03-02T01:26:44.000Z","date":"2017-02-27","kind":"exercise","acquired":true,"shares":3662,"price":30.63,"value":112167.06,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of options granted under the Amended and Restated Emergent BioSolutions Inc 2006 Stock Incentive Plan, as amended."}],"balance_after":192824,"source":{"system":"sec-edgar","filing":"0001140361-17-010111","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010111/doc1.xml","form_type":"4"}},{"id":4491813,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-13T02:59:16.000Z","date":"2017-01-10","kind":"exercise","acquired":true,"shares":38006,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F7","text":"Consists of an option granted under the company's stock incentive plan as amended and restated prior to the Spin-off."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option  grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":3662,"derivative":{"exercise_price":14.51,"expiration_date":"2017-03-08","underlying":"Common Stock","underlying_shares":38006},"source":{"system":"sec-edgar","filing":"0001140361-17-001760","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117001760/doc1.xml","form_type":"4"}},{"id":4491812,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to buy)","published_at":"2017-01-13T02:59:16.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":3662,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F6","text":"Represents options to purchase Emergent common stock awarded to the reporting person prior to the Spin-off . In connection with the Spin-off, the number of shares and exercise price of the option was adjusted, to preserve the pre-Spin-off intrinsic value of the existing Emergent option award."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"The option  grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":41668,"derivative":{"exercise_price":14.51,"expiration_date":"2017-03-08","underlying":"Common Stock","underlying_shares":3662},"source":{"system":"sec-edgar","filing":"0001140361-17-001760","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117001760/doc1.xml","form_type":"4"}},{"id":4491811,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-13T02:59:16.000Z","date":"2017-01-10","kind":"sale","acquired":false,"shares":28240,"price":31.2782,"value":883296.368,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $30.91 to $32.26, inclusive."}],"balance_after":189162,"source":{"system":"sec-edgar","filing":"0001140361-17-001760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117001760/doc1.xml","form_type":"4"}},{"id":4491810,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-13T02:59:16.000Z","date":"2017-01-10","kind":"exercise","acquired":true,"shares":38006,"price":14.51,"value":551467.06,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Mr. Abdun-Nabi."}],"balance_after":217402,"source":{"system":"sec-edgar","filing":"0001140361-17-001760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117001760/doc1.xml","form_type":"4"}},{"id":4491809,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-13T02:59:16.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":3419,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"In connection with the spin-off the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in March 2017, March 2018 and March 2019."}],"balance_after":179396,"source":{"system":"sec-edgar","filing":"0001140361-17-001760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117001760/doc1.xml","form_type":"4"}},{"id":4491808,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-13T02:59:16.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":3032,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"In connection with the spin-off on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in March 2017 and March 2018."}],"balance_after":175977,"source":{"system":"sec-edgar","filing":"0001140361-17-001760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117001760/doc1.xml","form_type":"4"}},{"id":4491807,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":25013,"kind":"person","name":"Abdun-Nabi Daniel","position":1,"cik":"0001380187","reported_name":"Abdun-Nabi Daniel","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-01-13T02:59:16.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":1979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"In connection with the spin-off (the \"Spin-off\") of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc. (\"Emergent\"), on August 1, 2016 the reporting person received a grant of restricted stock units as a result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the Spin-off. The restricted stock units vest in March 2017."}],"balance_after":172945,"source":{"system":"sec-edgar","filing":"0001140361-17-001760","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117001760/doc1.xml","form_type":"4"}}]}